Blood: The new alternative to the ditric ludes, acute grafts for host disease!
-
Last Update: 2020-07-12
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Acute Transplant Anti-Host Disease (GVHD) is a life-threatening complication of allo-HCTThe current GVHD treatment is primarily aimmunesystem that targets the donor, and a recent study in the journal Blood, Norona and others have explored a method designed to protect and regenerate Paneth cells (PCs) and intestinalstem cells(ISCs)researchers observed that acute GVHD reduced intestinal GLP-2 levels in mice and GVHD patientsIn several mouse models, treatments using GLP-2 agonists, teduglutide, reduce the occurrence of acute GVHD and steroid refractive GVHD with new hairstyles, and do not affect the effects of the graft anti-leukemia (GVL)in the mechanism, GLP-2 substitution promotes the regeneration of PC and ISC, thus enhancing the production of antimicrobial peptides and causing changes in the microbiomeGLP-2 expands intestinal organs and reduces the expression of apoptosis-related genesin patients receiving allo-HCT, the low number of L cells in intestinal tissue biopsies and high serum GLP-2 levels were associated with high non-recurrence mortality, this study suggests that L cells are a target for GVHD, and that GLP-2-based acute GVHD therapy can restore intestinal stability by increasing ISC and PC without affecting The Effect of GVLThe dyded ludtide is expected to become a new joint partner of GVHD immunosuppressive therapy and can be validated in clinical trialscover picture: The ditrilutide therapy reduced the loss of Paneth cells in GVHD mice
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
